April 20, 2020
Strongbridge Biopharma plc to Host First Quarter 2020 Financial Results Conference Call on May 6, 2020
Media
April 17, 2020
BONESUPPORT announces – De Novo application for CERAMENT G has been submitted to the FDA
April 16, 2020
James Noble appointed as Chairman of the Board
April 16, 2020
Report from Orexo´s annual general meeting, 16 April 2020
April 15, 2020
Vicore Pharma publishes the Annual Report for 2019
April 15, 2020
GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA
April 14, 2020
BONESUPPORT announces CERAMENT in combination with bisphosphonate shows promising results in preclinical long-term study
April 14, 2020
GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa
April 09, 2020
The board of directors of Orexo withdraws proposal on incentive program
April 08, 2020
Nordic Nanovector Announces New Date for Annual General Meeting
